Physiology and pathophysiology of organic acids in cerebrospinal fluid
Concentrations of organic acids in cerebrospinal fluid (CSF) appear to be directly dependent upon their rate of production in the brain. There is evidence that the net release of short-chain monocarboxylic acids from the brain is a major route for removing these products of cerebral metabolism. Conc...
Saved in:
Published in | Journal of inherited metabolic disease Vol. 16; no. 4; p. 648 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.01.1993
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Concentrations of organic acids in cerebrospinal fluid (CSF) appear to be directly dependent upon their rate of production in the brain. There is evidence that the net release of short-chain monocarboxylic acids from the brain is a major route for removing these products of cerebral metabolism. Concentrations of organic acids in blood and CSF are largely independent of each other. Quantitative reference values for the concentrations of organic acids in CSF and plasma as well as ratios of individual organic acids between CSF and plasma were determined in 35 pairs of samples from paediatric patients. Over 25 organic acids were quantifiable in all or in the majority of CSF and/or plasma specimens (limit of detection 1 mumol/L). There were substantial differences in the CSF/plasma ratios between subgroups of organic acids. Metabolites related to fatty-acid oxidation were present in CSF in substantially less amounts than in plasma. Organic acids related to carbohydrate and energy metabolism and to amino acid degradation were present in CSF in the same amounts as or slightly smaller amounts than in plasma. Finally, some organic acids were found in substantially higher amounts in CSF than in plasma, e.g. glycolate, glycerate, 2,4-dihydroxybutyrate, citrate and isocitrate. Studies of organic acids in CSF and plasma samples are presented from patients with 'cerebral' lactic acidosis, disorders of propionate and methylmalonate metabolism, glutaryl-CoA dehydrogenase deficiency and L-2-hydroxy-glutaric aciduria. It became apparent that derangements of organic acids in the CSF may occur independently of the systemic metabolism. Quantitative organic acid analysis in CSF will yield new information on the pathophysiology in the central nervous system (CNS) of these disorders and may prove necessary for successful monitoring of treatment of organoacidopathies, which present mainly with neurological disease. For example, in glutaryl-CoA dehydrogenase deficiency the urinary excretion of glutarate appears to be an inadequate parameter for monitoring the effect of dietary therapy, without plasma and CSF determinations. In L-2-hydroxyglutaric aciduria the elevation of L-2-hydroxyglutarate was found to be greater in CSF than in plasma. In addition, some other organic acids, glycolate, glycerate, 2,4-dihydroxybutyrate, citrate and isocitrate, were also elevated in the CSF of the patients out of proportion to normal levels in plasma and urine. High concentrations of an unknown compound, which was tentatively identified as 2,4-dihydroxyglutarate, were found in the CSF of patients with L-2-hydroxyglutaric aciduria. |
---|---|
AbstractList | Concentrations of organic acids in cerebrospinal fluid (CSF) appear to be directly dependent upon their rate of production in the brain. There is evidence that the net release of short-chain monocarboxylic acids from the brain is a major route for removing these products of cerebral metabolism. Concentrations of organic acids in blood and CSF are largely independent of each other. Quantitative reference values for the concentrations of organic acids in CSF and plasma as well as ratios of individual organic acids between CSF and plasma were determined in 35 pairs of samples from paediatric patients. Over 25 organic acids were quantifiable in all or in the majority of CSF and/or plasma specimens (limit of detection 1 mumol/L). There were substantial differences in the CSF/plasma ratios between subgroups of organic acids. Metabolites related to fatty-acid oxidation were present in CSF in substantially less amounts than in plasma. Organic acids related to carbohydrate and energy metabolism and to amino acid degradation were present in CSF in the same amounts as or slightly smaller amounts than in plasma. Finally, some organic acids were found in substantially higher amounts in CSF than in plasma, e.g. glycolate, glycerate, 2,4-dihydroxybutyrate, citrate and isocitrate. Studies of organic acids in CSF and plasma samples are presented from patients with 'cerebral' lactic acidosis, disorders of propionate and methylmalonate metabolism, glutaryl-CoA dehydrogenase deficiency and L-2-hydroxy-glutaric aciduria. It became apparent that derangements of organic acids in the CSF may occur independently of the systemic metabolism. Quantitative organic acid analysis in CSF will yield new information on the pathophysiology in the central nervous system (CNS) of these disorders and may prove necessary for successful monitoring of treatment of organoacidopathies, which present mainly with neurological disease. For example, in glutaryl-CoA dehydrogenase deficiency the urinary excretion of glutarate appears to be an inadequate parameter for monitoring the effect of dietary therapy, without plasma and CSF determinations. In L-2-hydroxyglutaric aciduria the elevation of L-2-hydroxyglutarate was found to be greater in CSF than in plasma. In addition, some other organic acids, glycolate, glycerate, 2,4-dihydroxybutyrate, citrate and isocitrate, were also elevated in the CSF of the patients out of proportion to normal levels in plasma and urine. High concentrations of an unknown compound, which was tentatively identified as 2,4-dihydroxyglutarate, were found in the CSF of patients with L-2-hydroxyglutaric aciduria. |
Author | Hoffmann, G F Rating, D Surtees, R Nyhan, W L Stöckler, S Meier-Augenstein, W |
Author_xml | – sequence: 1 givenname: G F surname: Hoffmann fullname: Hoffmann, G F organization: Department of Pediatrics, University of Heidelberg, Germany – sequence: 2 givenname: W surname: Meier-Augenstein fullname: Meier-Augenstein, W – sequence: 3 givenname: S surname: Stöckler fullname: Stöckler, S – sequence: 4 givenname: R surname: Surtees fullname: Surtees, R – sequence: 5 givenname: D surname: Rating fullname: Rating, D – sequence: 6 givenname: W L surname: Nyhan fullname: Nyhan, W L |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/8412012$$D View this record in MEDLINE/PubMed |
BookMark | eNpFj81KAzEURrOo1La6cS_kBUZvMjeTZKnFUaGgC12X_LaRaTJM7KJvr2DBzXfgLA58SzLLJQdCbhjcMQB5_9j_LmNKqxlZAEPWKC3EJVnW-gUAWgkxJ3OFjAPjC9K_7081laHsTtRkT0fzvS_jvyuRlmlncnLUuOQrTZm6MAU7lTqmbAYah2PyV-QimqGG6zNX5LN_-li_NJu359f1w6ZxyJRqrPXSYOwCekAB1oMXnTdCc45opZSGiVb6loPVGlkXwUEbMVp0Qcbg-Irc_nXHoz0Evx2ndDDTaXv-w38A30pMLw |
CitedBy_id | crossref_primary_10_1002_jimd_12599 crossref_primary_10_1016_S0378_4347_98_00136_4 crossref_primary_10_1016_j_expneurol_2005_09_002 crossref_primary_10_1007_s11306_019_1571_9 crossref_primary_10_1023_A_1015165212965 crossref_primary_10_1002_jimd_12636 crossref_primary_10_1016_S0197_0186_05_80011_7 crossref_primary_10_1016_j_taap_2022_116143 crossref_primary_10_3390_nutraceuticals1010006 crossref_primary_10_1038_s41467_021_22272_3 crossref_primary_10_15252_embr_201338064 crossref_primary_10_1016_S0925_4439_01_00088_6 crossref_primary_10_1172_JCI34138 crossref_primary_10_1002_jnr_10735 crossref_primary_10_1007_s10545_006_0415_8 crossref_primary_10_1016_j_molcel_2018_04_011 crossref_primary_10_20538_1682_0363_2012_1_128_134 crossref_primary_10_3109_00498254_2013_791410 crossref_primary_10_1007_s10571_022_01236_1 crossref_primary_10_1016_j_chroma_2007_11_047 crossref_primary_10_1016_j_ijdevneu_2005_10_005 crossref_primary_10_1016_j_carres_2006_06_023 crossref_primary_10_1016_S0957_5839_05_80060_0 crossref_primary_10_1016_j_brainres_2009_08_080 crossref_primary_10_1021_acscentsci_8b00879 crossref_primary_10_1016_j_ymgme_2018_06_008 crossref_primary_10_1021_ac801185e crossref_primary_10_1203_00006450_199609000_00007 crossref_primary_10_1038_s41598_023_41765_3 crossref_primary_10_1371_journal_pone_0181758 crossref_primary_10_1016_j_tibs_2015_01_004 crossref_primary_10_1111_jnc_14693 crossref_primary_10_1016_j_ijdevneu_2008_07_011 crossref_primary_10_1093_hmg_ddh300 crossref_primary_10_1016_S0006_8993_98_00563_0 crossref_primary_10_3390_ijms21239137 crossref_primary_10_1007_s11011_010_9190_1 crossref_primary_10_1007_s11064_006_9054_6 crossref_primary_10_1002_rcm_4156 crossref_primary_10_1016_0006_8993_96_00117_5 crossref_primary_10_1016_j_neuint_2010_04_002 crossref_primary_10_1016_j_ymben_2022_12_008 crossref_primary_10_1021_acs_chemrev_1c00746 crossref_primary_10_1213_ANE_0000000000005926 crossref_primary_10_1186_s12877_024_04759_y crossref_primary_10_1007_s11064_016_2154_z crossref_primary_10_1002_mrd_23082 crossref_primary_10_1007_BF02815059 crossref_primary_10_1016_j_brainres_2010_02_018 crossref_primary_10_1007_BF01955272 crossref_primary_10_1007_s11306_013_0582_1 crossref_primary_10_1016_j_expneurol_2006_04_004 crossref_primary_10_1016_j_taap_2018_03_017 crossref_primary_10_1007_s10545_006_9998_3 crossref_primary_10_1016_j_jchromb_2014_01_041 crossref_primary_10_1016_S0006_8993_97_00415_0 crossref_primary_10_3390_ijms231911693 crossref_primary_10_1016_j_ymgme_2021_03_017 crossref_primary_10_1016_0378_4347_95_00115_Y crossref_primary_10_1016_j_mam_2009_12_006 crossref_primary_10_1007_s12035_015_9289_9 crossref_primary_10_1016_j_jchromb_2020_121982 crossref_primary_10_15583_jpchrom_2022_011 crossref_primary_10_1016_j_jns_2005_12_005 crossref_primary_10_1016_j_chroma_2013_04_005 crossref_primary_10_1002_dta_3399 crossref_primary_10_1038_s41380_022_01752_y crossref_primary_10_1016_j_jpba_2021_114450 crossref_primary_10_3390_jcm6070071 crossref_primary_10_1007_s11064_005_7711_9 crossref_primary_10_1021_acschemneuro_1c00119 crossref_primary_10_1016_j_brainres_2004_10_010 crossref_primary_10_1016_S0192_0561_97_85559_2 crossref_primary_10_1007_s11011_009_9131_z crossref_primary_10_1016_j_clinms_2019_11_002 crossref_primary_10_1016_j_lfs_2007_12_024 crossref_primary_10_1007_s12640_018_9874_6 crossref_primary_10_1007_BF00711767 crossref_primary_10_1016_j_jns_2003_10_005 crossref_primary_10_1007_BF00970591 crossref_primary_10_1007_s10571_011_9675_4 crossref_primary_10_1016_j_pain_2013_10_005 crossref_primary_10_1002_jcp_30981 crossref_primary_10_1007_s00216_006_0911_6 crossref_primary_10_1007_s11011_012_9327_5 crossref_primary_10_1016_j_neuroscience_2016_10_049 crossref_primary_10_1016_j_ijdevneu_2009_08_004 crossref_primary_10_1016_S0006_8993_03_02722_7 crossref_primary_10_1016_j_toxlet_2018_06_1070 crossref_primary_10_1007_BF02138786 crossref_primary_10_1016_j_jns_2007_04_011 crossref_primary_10_1186_gm337 crossref_primary_10_3390_metabo12070610 crossref_primary_10_1016_j_neuint_2015_11_005 crossref_primary_10_1016_j_ymgme_2011_10_003 crossref_primary_10_1007_s10863_011_9330_2 crossref_primary_10_1006_exnr_1997_6602 crossref_primary_10_1007_s10571_012_9879_2 crossref_primary_10_1016_j_ntt_2006_04_003 crossref_primary_10_1021_bi200499m crossref_primary_10_1039_b913468a crossref_primary_10_1186_s13195_017_0303_5 crossref_primary_10_1016_j_jpba_2022_114738 crossref_primary_10_1134_S1054661814020151 crossref_primary_10_3390_metabo11120835 crossref_primary_10_1016_j_clinbiochem_2019_04_004 crossref_primary_10_1016_j_jchromb_2023_123719 crossref_primary_10_1016_j_neuint_2010_03_009 crossref_primary_10_1016_j_xphs_2021_01_025 crossref_primary_10_1016_S0197_0186_01_00130_9 crossref_primary_10_1016_j_jchromb_2008_05_001 crossref_primary_10_1371_journal_pone_0053735 crossref_primary_10_1002_jmri_10270 crossref_primary_10_1007_s11011_007_9046_5 crossref_primary_10_1007_s11011_006_9041_2 crossref_primary_10_1016_j_ijdevneu_2010_10_007 crossref_primary_10_1097_RMR_0b013e31804c99d4 crossref_primary_10_17116_jnevro201611612196_103 crossref_primary_10_1016_S0021_9673_97_00317_8 crossref_primary_10_1007_s10545_007_0798_1 crossref_primary_10_1007_s11011_010_9204_z crossref_primary_10_1073_pnas_1603023113 crossref_primary_10_1016_j_neuroscience_2021_07_024 crossref_primary_10_1007_s12035_022_02930_3 crossref_primary_10_1177_197140090001300513 crossref_primary_10_15583_jpchrom_2023_015 crossref_primary_10_1038_tp_2011_55 crossref_primary_10_1016_j_neuropharm_2016_05_006 crossref_primary_10_1186_1750_1172_8_98 crossref_primary_10_3390_cells10123388 crossref_primary_10_1016_S0022_3476_95_70208_3 crossref_primary_10_1016_j_lfs_2008_04_015 crossref_primary_10_1039_C6MB00424E crossref_primary_10_1023_A_1005359416197 crossref_primary_10_1007_s11306_010_0250_7 crossref_primary_10_1016_j_mrgentox_2010_07_008 crossref_primary_10_1246_cl_150153 crossref_primary_10_1007_s11011_013_9396_0 crossref_primary_10_1111_bjh_18307 crossref_primary_10_1590_S0100_879X2001000500010 crossref_primary_10_1007_s10545_009_1197_6 crossref_primary_10_1007_s11011_006_9002_9 crossref_primary_10_1590_S0100_879X2001000200010 crossref_primary_10_1002_jnr_21527 crossref_primary_10_1093_jnen_nlw121 crossref_primary_10_3389_fmolb_2021_682134 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1007/BF00711898 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 8412012 |
Genre | Research Support, U.S. Gov't, P.H.S Review Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: NINDS NIH HHS grantid: NS22343 |
GroupedDBID | --- -53 -5E -5G -BR -Y2 -~C .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 1OB 1OC 1SB 2.D 203 28- 29K 29~ 2J2 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 33P 3SX 3V. 4.4 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8UJ 95- 95. 95~ 96X AAAVM AABHQ AAHHS AAIAL AAJKR AANLZ AANXM AARHV AARTL AASGY AATVU AAWCG AAXRX AAYIU AAYQN AAYTO AAYZH ABBBX ABBXA ABCUV ABHLI ABIPD ABJOX ABKTR ABMNI ABNWP ABPLI ABPPZ ABQBU ABQWH ABTEG ABTMW ABUWG ABUWZ ACAHQ ACBXY ACCFJ ACCZN ACGFS ACHXU ACKNC ACOKC ACOMO ACPOU ACPRK ACUDM ACXBN ACXQS ADBBV ADHHG ADHIR ADIMF ADINQ ADKPE ADKYN ADMGS ADOZA ADRFC ADXAS ADZKW ADZMN AEBTG AEEZP AEFIE AEGAL AEGNC AEIGN AEJHL AEKMD AENEX AEOHA AEPYU AEQDE AETLH AEUYR AEXYK AFBBN AFEXP AFFNX AFFPM AFGKR AFKRA AFLOW AFWTZ AFZKB AGAYW AGGDS AGJBK AGQMX AGWIL AGWZB AGYKE AHAVH AHBTC AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIIXL AITYG AIURR AIWBW AJBDE AJBLW AJRNO AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN ALWAN AMKLP AMYDB AMYQR ARMRJ ASPBG AVWKF AZFZN B-. BA0 BBWZM BDATZ BENPR BFHJK BGNMA BPHCQ BVXVI C45 CAG CCPQU CGR COF CS3 CSCUP CUY CVF D-I DCZOG DL5 DRFUL DRSTM DU5 DUUFO EBD EBS ECM EIF EJD EMOBN EN4 EPAXT ESBYG F5P FEDTE FIGPU FNLPD FRRFC FWDCC FYUFA G-Y G-Z GGCAI GGRSB GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HGLYW HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- ITM IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX KDC KOV KOW KPH LAK LATKE LEEKS LYRES M1P M4Y MA- MEWTI MXFUL MXSTM N2Q NB0 NDZJH NPM NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P2W P9S PF0 PQQKQ PROAC PSQYO PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S37 S3B SAMSI SAP SCLPG SDE SDH SDM SHX SISQX SMD SNE SNX SOJ SPISZ SSXJD SUPJJ SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP VC2 W23 W48 WH7 WJK WK6 WK8 WXSBR X7M YLTOR Z45 Z7U Z7W Z82 Z87 Z8O Z8Q Z8V Z91 ZGI ZMTXR ZOVNA ZZTAW ~EX ~KM |
ID | FETCH-LOGICAL-c4188-bbd7a4f6e4d0450bd0d56da592244b777a1537d320b99416f0c03f4fb4ce7fec2 |
ISSN | 0141-8955 |
IngestDate | Wed Oct 16 00:48:09 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4188-bbd7a4f6e4d0450bd0d56da592244b777a1537d320b99416f0c03f4fb4ce7fec2 |
PMID | 8412012 |
ParticipantIDs | pubmed_primary_8412012 |
PublicationCentury | 1900 |
PublicationDate | 1993-01-01 |
PublicationDateYYYYMMDD | 1993-01-01 |
PublicationDate_xml | – month: 01 year: 1993 text: 1993-01-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of inherited metabolic disease |
PublicationTitleAlternate | J Inherit Metab Dis |
PublicationYear | 1993 |
SSID | ssj0009855 |
Score | 1.7860556 |
SecondaryResourceType | review_article |
Snippet | Concentrations of organic acids in cerebrospinal fluid (CSF) appear to be directly dependent upon their rate of production in the brain. There is evidence that... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 648 |
SubjectTerms | Amino Acids - cerebrospinal fluid Animals Blood-Brain Barrier - physiology Brain - metabolism Carboxylic Acids - cerebrospinal fluid Humans Metabolism, Inborn Errors - cerebrospinal fluid |
Title | Physiology and pathophysiology of organic acids in cerebrospinal fluid |
URI | https://www.ncbi.nlm.nih.gov/pubmed/8412012 |
Volume | 16 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LSsQwFA0-UNyIT3yThTuptJ0kbZYq6iDoRgV30iQ3MOA8GDsbv96bJmPbUfGxKSUppe05TU-Te88l5FhBIRId8yjXICNn4BUpqVlkmFLc6ByEj7a4E91HdvPEn-rJnCq7pFSn-u3LvJL_oIptiKvLkv0Dsh8nxQbcR3xxiwjj9lcYV-GbtYmSqy48HNVtqAN90SZ9Uuiej3zVMMa_YFcsxMlQ-zLptSp13jSNJFxqoBOkfSiRKs4Ne2Y5pzu0th-qLF_XMcK3gN_a6GyC1_06LaZZT-WUbm3-XLgl5XbNr_vJuARoRDGakJ3XaUxGTOcnkyiX3nn3Y4AVDSKxxmgpvMnmp1E8nsamo_5Jctk6CBEY9Ss8c5agekl_7Jzx0w4982Q-y93AeOemd6YuzTkPMa_-Ltp-tuFqVshSOMfMr0glSR7WyGrAip55YqyTORhskOXbEC2xSa5qflDkB53hBx1aGvhBK37Q3oC2-EErfmyRx6vLh4tuFOpmRJol-IooZbKCWQHMoGCPlYkNF6bgEuUaU1mWFfiZy0wnjZWUKMhtrOOOZVYxDZkFnW6ThcFwADuExpBYmYBMpMFekRZFWljlZA_nAnhnl2z7J_A88uYoz-HR7H3XsU9WauIckEWL7yIcorAr1VEFxjvqAU2e |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Physiology+and+pathophysiology+of+organic+acids+in+cerebrospinal+fluid&rft.jtitle=Journal+of+inherited+metabolic+disease&rft.au=Hoffmann%2C+G+F&rft.au=Meier-Augenstein%2C+W&rft.au=St%C3%B6ckler%2C+S&rft.au=Surtees%2C+R&rft.date=1993-01-01&rft.issn=0141-8955&rft.volume=16&rft.issue=4&rft.spage=648&rft_id=info:doi/10.1007%2FBF00711898&rft_id=info%3Apmid%2F8412012&rft_id=info%3Apmid%2F8412012&rft.externalDocID=8412012 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0141-8955&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0141-8955&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0141-8955&client=summon |